Synthon Pharmaceuticals, Inc. Company Profile
Synthon is an independent group of affiliated pharmaceutical companies dedicated to the development, registration, production, marketing and distribution of a wide range of pharmaceutical products. Founded in 1991, Synthon has developed into a successful and dynamic organization that operates on a global scale, combining its own strength in the field of R&D with the distribution and sales expertise of its marketing partners. Synthon’s innovative character is reflected by the number of global patents held by its group members.
Product portfolio selection of sophisticated pharmaceuticals coupled with a fast-track R&D strategy enables us to offer our marketing partners the advantage of being first to market and a considerable edge in an increasingly competitive market.
9000 Development Drive P.O. Box 110487
Research Triangle Park
United States of America
Phone: 1 (919) 493-6006
Fax: 1 (919) 493-6104
Drugs and Medications
SIMVASTATIN ORALLY DISINTEGRATING TABLETS(SIMVASTATIN)
These highlights do not include all the information needed to use levocetirizine dihydrochloride tablets safely and effectively. See full prescribing information for levocetirizine dihydrochloride tab...
These highlights do not include all the information needed to use Bicalutamide Tablets, USP safely and effectively. See full prescribing information for Bicalutamide Tablets, USP. Bicalutamide Tablet...
These highlights do not include all the information needed to use tamsulosin hydrochloride capsules, USP safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules,...
Amlodipine Besylate Tablets
Ethyl (R)-4-cyano-3-hydroxybutanoate (HN) is an important chiral synthon for side chain of the cholesterol-lowering drug atorvastatin (Lipitor), which is the hydroxymethylglutaryl CoA reductase inhibi...
[Et4N]2[Mo(IV)O(mnt)2] (mnt = maleonitriledithiolate) reacts, as a synthon, with Me3SiCN under an acidic medium to produce the square complex [Et4N]4[Mo4(μ-CN)4(mnt)8] (1) in high yield. Complex 1 sh...
o-Carboryne (1,2-dehydro-o-carborane) is a very reactive intermediate that can be generated in situ from 1-Br-2-Li-1,2-C2B10H10, 1-I-2-Li-1,2-C2B10H10 or 1-Me3Si-2-[IPh(OAc)]-1,2-C2B10H10. It exists i...
The title compound [systematic name: (4,4-dimethyl-8-methylene-3-azabicyclo[3.3.1]non-2-en-2-yl)(1H-indol-3-yl)methanone], C20H22N2O, (II), was obtained from mother liquors extracted from Aristotelia...
Synthon is an independent group of affiliated pharmaceutical companies dedicated to the development, registration, production, marketing and distribution of a wide range of pharmaceutical products. Fo...
Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for deca...
More Information about "Synthon Pharmaceuticals, Inc." on BioPortfolio
We have published hundreds of Synthon Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Synthon Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Synthon Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synthon Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Synthon Pharmaceuticals, Inc. Drugs and Medications on this site too.